Adaptimmune Therapeutics 2024 Annual Report 10-K

Loading viewer...

annual_report

Format: PDF annual_report

Adaptimmune Therapeutics PLC's 2024 annual report filing with the SEC, covering fiscal year ended December 31, 2024. The company is a biopharmaceutical firm developing cell therapy treatments, headquartered in Abingdon, UK, trading on Nasdaq under ticker ADAP.

Browse all annual_reports →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Adaptimmune Therapeutics

View all →

presentation

Similar annual_reports from other companies

Browse all →

Alma Media Annual Report 2003

annual_report

84 Pages

Alma Media

ACCO Brands 2023 Annual Report Form 10-K

annual_report